Bracket: new IRT solution enables go-live in 1 to 2 weeks
According to the clinical trial technology and specialty services provider, the new solution – CUBE – addresses two challenges inherent to software implementation: time to build and time to change.
“CUBE is a unique solution for the industry that enables study teams to streamline IRT implementation by eliminating the need for cumbersome requirement documentation,” Jim Primerano, senior vice president and general manager, eClinical, Bracket, told Outsourcing-Pharma.com.
“CUBE supports an automated deployment model that allows customers to focus on their user acceptance experience to finalize study configuration parameters, reducing time to deployment and post system deployment changes,” he said.
The system leverages Bracket’s randomization and trial supply management (RTSM) platform and supports most trial design constructs, according to the company. It is also modifiable in near real-time and enables sponsors to experience the system before requirements approval.
According to Primerano, by streamlining implementation users can complete a full system go live in one to two weeks.
“Managing compressed timelines is a universal challenge in drug development,” he said. “With CUBE, we are significantly reducing the burden on study managers by eliminating complexity and workload during trial initiation activities.”
